You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
16 March 2021
Stada has entered the US consumer healthcare market with two new dietary supplement brands – Bio360 and Nuvia – and plans to launch a broad range of non-prescription products in the country over the next two to three years.
16 March 2021
Acquisitions helped lift sales at Stada’s Branded Products division by almost a third in 2020 but sales in the German company’s home market dropped by around a quarter. Chief executive officer Peter Goldschmidt says Stada is now the fifth largest player in the European consumer healthcare market.
25 February 2021
Stada has captured the OTCToolbox Consumer Healthcare Industry (CHi) Award for Business Development Team of the Year thanks to a series of significant deals.
10 February 2021
Thornton & Ross has strengthened its research and development, communications and marketing teams with three senior appointments.
29 January 2021
Stada has welcomed a recommendation from Germany’s Expert Committee for Prescription that the antibiotic mixture tyrothricin should remain available without a prescription for treating mouth and throat problems.
22 January 2021
Germany’s Stada has appointed Volker Sydow to the new post of head of global consumer health.
9 December 2020
Germany’s Stada has inlicensed rights to Enzymatica’s ViruProtect common cold spray in the Nordic region excluding Sweden.
20 November 2020
Switch specialist Maxwellia has created a new position, Stada has appointed a global head of digital communications, and the Pharmaceutical Group of the European Union (PGEU) has a new president.
14 October 2020
Germany’s Stada has inlicensed exclusive rights to Enzymatica’s ViruProtect cold spray in an additional 14 countries including Poland, Russia and Ukraine.
29 September 2020
Stada has recruited Yann Brun, managing director of Exeltis, as a member of its global leadership team with effect from 1 October 2020.